Literature DB >> 15485634

Act1, a negative regulator in CD40- and BAFF-mediated B cell survival.

Youcun Qian1, Jinzhong Qin, Grace Cui, Mayumi Naramura, E Charles Snow, Carl F Ware, Robert L Fairchild, Sidne A Omori, Robert C Rickert, Martin Scott, Brian L Kotzin, Xiaoxia Li.   

Abstract

TNF receptor (TNFR) superfamily members, CD40, and BAFFR play critical roles in B cell survival and differentiation. Genetic deficiency in a novel adaptor molecule, Act1, for CD40 and BAFF results in a dramatic increase in peripheral B cells, which culminates in lymphadenopathy and splenomegaly, hypergammaglobulinemia, and autoantibodies. While the B cell-specific Act1 knockout mice displayed a similar phenotype with less severity, the pathology of the Act1-deficient mice was mostly blocked in CD40-Act1 and BAFF-Act1 double knockout mice. CD40- and BAFF-mediated survival is significantly increased in Act1-deficent B cells, with stronger IkappaB phosphorylation, processing of NF-kappaB2 (p100/p52), and activation of JNK, ERK, and p38 pathways, indicating that Act1 negatively regulates CD40- and BAFF-mediated signaling events. These findings demonstrate that Act1 plays an important role in the homeostasis of B cells by attenuating CD40 and BAFFR signaling.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15485634     DOI: 10.1016/j.immuni.2004.09.001

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  73 in total

Review 1.  Function of Act1 in IL-17 family signaling and autoimmunity.

Authors:  Ling Wu; Jarod Zepp; Xiaoxia Li
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

Review 2.  Use of forward genetics to discover novel regulators of NF-kappaB.

Authors:  Tao Lu; George R Stark
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-23       Impact factor: 10.005

3.  Act1 mediates IL-17-induced EAE pathogenesis selectively in NG2+ glial cells.

Authors:  Zizhen Kang; Chenhui Wang; Jarod Zepp; Ling Wu; Kevin Sun; Junjie Zhao; Unni Chandrasekharan; Paul E DiCorleto; Bruce D Trapp; Richard M Ransohoff; Xiaoxia Li
Journal:  Nat Neurosci       Date:  2013-09-01       Impact factor: 24.884

Review 4.  Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy.

Authors:  Fang Shen; Sarah L Gaffen
Journal:  Cytokine       Date:  2008-01-04       Impact factor: 3.861

5.  An inactivated Pseudomonas aeruginosa medicament inhibits airway allergic inflammation and improves epithelial functions.

Authors:  Yurong Tan; Huijun Liu; Huihui Yang; Lili Wang; Xiaoqun Qin
Journal:  J Physiol Sci       Date:  2012-09-26       Impact factor: 2.781

6.  Differential TRAF3 utilization by a variant human CD40 receptor with enhanced signaling.

Authors:  Anna L Peters; Gail A Bishop
Journal:  J Immunol       Date:  2010-11-01       Impact factor: 5.422

Review 7.  Roles for TNF-receptor associated factor 3 (TRAF3) in lymphocyte functions.

Authors:  Zuoan Yi; Wai Wai Lin; Laura L Stunz; Gail A Bishop
Journal:  Cytokine Growth Factor Rev       Date:  2013-12-25       Impact factor: 7.638

8.  LKB1 inhibition of NF-κB in B cells prevents T follicular helper cell differentiation and germinal center formation.

Authors:  Nicole C Walsh; Lynnea R Waters; Jessica A Fowler; Mark Lin; Cameron R Cunningham; David G Brooks; Jerold E Rehg; Herbert C Morse; Michael A Teitell
Journal:  EMBO Rep       Date:  2015-04-26       Impact factor: 8.807

9.  Increased Act1/IL-17R expression in Hirschsprung's disease.

Authors:  Christian Tomuschat; Anne Marie O'Donnell; David Coyle; Prem Puri
Journal:  Pediatr Surg Int       Date:  2016-09-22       Impact factor: 1.827

10.  An essential role of interleukin-17 receptor signaling in the development of autoimmune glomerulonephritis.

Authors:  Kritika Ramani; Sudesh Pawaria; Kelly Maers; Anna R Huppler; Sarah L Gaffen; Partha S Biswas
Journal:  J Leukoc Biol       Date:  2014-06-16       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.